Kochi
Kochi
Kochi, Kochi, Japan16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years | brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Recruiting | Phase 3 | 2026-10-09 | NCT06810505 | |
| A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine | Episodic Migraine | Recruiting | Phase 3 | 2026-10-06 | NCT05711394 | |
| A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-09-28 | NCT07144280 | |
| Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects | Ear Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Photophobia, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, eye disorder, headache disorder, hearing disorder, hyperacusis, hypnic headache, migraine disorder, nervous system disorder, otorhinolaryngologic disease, vision disorder | Recruiting | Phase 3 | 2026-09-28 | NCT05156398 | |
| Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine | Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder | Active, not recruiting | Phase 3 | 2026-09-21 | NCT03836040 | |
| A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA) | Genital Diseases, Urogenital Diseases, infertility disorder | Recruiting | Phase 3 | 2026-09-08 | NCT07340827 | |
| Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine | Menstrual Migraine (MM) | Active, not recruiting | Phase 3 | 2026-09-04 | NCT06806293 | |
| Study of BK1803 in Healthy Infants | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Blood-Borne Infections, Clostridium infectious disease, Corynebacterium Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, Neuroinflammatory Diseases, Pasteurellaceae Infections, Picornaviridae infectious disease, RNA Virus Infections, bacterial infectious disease, bordetellosis, central nervous system disorder, central nervous system infectious disorder, diphtheria, enterovirus infectious disease, gram-negative bacterial infections, gram-positive bacterial infections, haemophilus infectious disease, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, myelitis, nervous system disorder, neuromuscular disease, pertussis, poliomyelitis, respiratory system disorder, respiratory tract infectious disorder, spinal cord disorder, tetanus, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 3 | 2026-08-28 | NCT07793513 | |
| Pancreatic Cancer Screening Using the Enzeavour Assay in Japan | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not applicable | 2026-06-26 | NCT07605819 | |
| RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | Bone Diseases, Metabolic, Femoral Fractures, Hip Injuries, Leg Injuries, Nutritional and Metabolic Diseases, bone disorder, bone fracture, hip fracture, injury, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Not applicable | 2026-05-13 | NCT04796350 | |
| A Clinical Study of the Paradise™ Renal Denervation System in Patients With Hypertension (RADIANCE-HTN DUO) | cardiovascular disorder, hypertensive disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-04-15 | NCT05326230 | |
| Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-02-27 | NCT05581303 | |
| An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan | Crohn disease, Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Not stated | 2026-02-24 | NCT06023030 | |
| Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure | Acute Heart Failure | Recruiting | Phase 3 | 2026-02-13 | NCT05392764 | |
| Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine | Migraine Prophylaxis | Enrolling by invitation | Phase 3 | 2025-08-11 | NCT05707949 | |
| Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry) | Angina Pectoris, Angina, Stable, Chest Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, intermediate coronary syndrome, myocardial ischemia, vascular disorder | Recruiting | Not stated | 2025-03-13 | NCT06436092 |